Psychotic Disorders - Bangladesh | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$36.82m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.93%, resulting in a market volume of US$38.55m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$30.99 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Bangladesh is witnessing significant growth due to several factors such as changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Psychotic Disorders market in Bangladesh are shifting towards more accessible and affordable treatment options. As the country's healthcare infrastructure improves, there is an increasing demand for psychiatric services and medications. Customers are seeking effective treatments that can help manage their symptoms and improve their quality of life. Additionally, there is a growing awareness and acceptance of mental health issues in the society, leading to a higher demand for treatments for psychotic disorders.Trends in the market include the adoption of innovative therapies and the integration of technology in healthcare. Pharmaceutical companies are investing in research and development to introduce new medications with improved efficacy and fewer side effects. This is driving the growth of the market as healthcare professionals and patients are looking for more advanced treatment options. Furthermore, the use of telemedicine and digital health platforms is gaining popularity, allowing patients to access psychiatric services remotely and receive timely treatment.Local special circumstances in Bangladesh contribute to the development of the Psychotic Disorders market. The country has a large population and a high prevalence of mental health disorders, including psychotic disorders. This creates a significant market opportunity for pharmaceutical companies and healthcare providers. Additionally, the government has been actively working towards improving mental healthcare services and increasing access to treatment. This includes the establishment of specialized mental health facilities and the integration of mental health services into primary healthcare centers.Underlying macroeconomic factors also play a role in the growth of the Psychotic Disorders market in Bangladesh. The country has been experiencing steady economic growth, resulting in an increase in disposable income and healthcare expenditure. As people have more financial resources, they are able to afford better healthcare services, including treatments for psychotic disorders. Moreover, the government's focus on healthcare development and the implementation of health insurance schemes have further facilitated access to treatment for the population.In conclusion, the Psychotic Disorders market in Bangladesh is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The demand for accessible and effective treatments, the adoption of innovative therapies, the integration of technology in healthcare, the high prevalence of mental health disorders, the government's efforts to improve mental healthcare services, and the country's economic growth all contribute to the growth of the market. As the market continues to evolve, it is expected to provide better treatment options and improved outcomes for patients with psychotic disorders in Bangladesh.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.